BackVascular Biogenics Overview

Vascular Biogenics Research & Development

Research & Development expenses for VBLT.

Quarterly R&D Expenses

$2.35M
↓ 252.26% YoY

As of Jun 30, 2024

Annual R&D Expenses (TTM)

$2.39M
↓ 90.96% YoY

Trailing 12 months ending Jun 30, 2024

Average R&D Expenses (Comparison Companies)

Research & Development History

Research & Development Comparison

Annual Research & Development Growth Rate (%)

Annual Research & Development Growth (Absolute)

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin